Multivitamin and Meropenem drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Multivitamin (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e) and Meropenem (meropenem). Common drug interactions include dizziness among females and respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Multivitamin and Meropenem. It is created by eHealthMe based on reports of 98 people who take the same drugs from the FDA, and is updated regularly.

What is Multivitamin?

Multivitamin has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 83,597 Multivitamin users. Check the latest studies of Multivitamin.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 22, 2026

98 people who take Multivitamin and Meropenem together, and have interactions are studied.

Multivitamin and Meropenem drug interactions.

What are the common drug interactions of Multivitamin and Meropenem, by gender? *:

female:

  1. Dizziness
  2. Dyspnoea (difficult or laboured respiration)
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Hypercapnia (too much smoke)
  5. Hypoxia (low oxygen in tissues)
  6. Lung infection
  7. Oedema peripheral (superficial swelling)
  8. Productive cough
  9. Sputum discoloured
  10. Aspartate aminotransferase increased

male:

  1. Respiratory failure (inadequate gas exchange by the respiratory system)
  2. Hypotension (abnormally low blood pressure)
  3. Aspergillosis (an infection caused by a fungus called aspergillus)
  4. Cardiac arrest
  5. Cardiac failure
  6. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  7. Dyspnoea (difficult or laboured respiration)
  8. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  9. Hypoxia (low oxygen in tissues)
  10. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

What are the common drug interactions of Multivitamin and Meropenem, by age (0-1 to 60+)? *:

0-1:

  1. Acute respiratory failure
  2. Anaphylactic reaction (serious allergic reaction)
  3. Bronchopulmonary dysplasia (chronic lung disorder in infants - enlargement of an organ or tissue by the proliferation of cells of an abnormal type)
  4. Dyspnoea (difficult or laboured respiration)
  5. Flatulence (flatus expelled through the anus)
  6. General physical health deterioration (weak health status)
  7. Increased bronchial secretion
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Pulmonary hypertension (increase in blood pressure in the lung artery)
  10. Pyrexia (fever)

2-9:

  1. Respiratory failure (inadequate gas exchange by the respiratory system)
  2. Cardiac failure
  3. Pneumonia
  4. Cerebral haemorrhage (bleeding within the brain)
  5. Haemolytic uraemic syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more)
  6. Infection
  7. Interstitial lung disease
  8. Pneumonia viral
  9. Stem cell transplant
  10. Cytomegalovirus hepatitis (virus infection of liver)

10-19:

  1. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  2. Decreased appetite
  3. Dyspnoea (difficult or laboured respiration)
  4. Staphylococcal infection (an infection with staphylococcus bacteria)
  5. Weight decreased
  6. Asthma
  7. Cough
  8. Drug abuse
  9. Fatigue (feeling of tiredness)
  10. Haematemesis (vomiting of blood)

20-29:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Blood creatine phosphokinase increased
  3. Cystic fibrosis (disease of the secretary glands)
  4. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  5. Infection
  6. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  7. Lung disorder (lung disease)
  8. Pain in extremity

30-39:

  1. Bruxism (habitual grinding of the teeth, typically during sleep)
  2. Stereotypy (excessive repetition or lack of variation in movements, ideas, or patterns of speech)
  3. Anaemia (lack of blood)
  4. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  5. Splenic infarction (tissue damage of spleen)
  6. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Lung infection pseudomonal (bacterial infection of lung by pseudomonas aeruginosa)
  10. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

40-49:

  1. Abdominal pain upper
  2. Acute respiratory failure
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Cough
  5. Dizziness
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  8. Hypercapnia (too much smoke)
  9. Hypotension (abnormally low blood pressure)
  10. Hypoxia (low oxygen in tissues)

50-59:

  1. Hyperbilirubinaemia (excess of bilirubin in the blood)
  2. Pericardial effusion (fluid around the heart)
  3. Renal tubular necrosis (death of kidney tubules)
  4. Therapeutic response decreased (less preventive response)
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Anaemia (lack of blood)
  7. Atelectasis (partial or complete collapse of the lung)
  8. Back pain
  9. Bacteraemia (presence of bacteria in the blood)
  10. Blood cholesterol increased

60+:

  1. Respiratory failure (inadequate gas exchange by the respiratory system)
  2. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  3. Confusional state
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Gait disturbance
  6. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  7. Hallucination (an experience involving the perception of something not present)
  8. Muscular weakness (muscle weakness)
  9. Nocardiosis (an infectious disease affecting either the lungs or whole body)
  10. Pleural effusion (water on the lungs)

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 14 people, 14.29%
  2. Pain: 11 people, 11.22%
  3. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 10 people, 10.20%
  4. Cystic Fibrosis (disease of the secretary glands): 10 people, 10.20%
  5. Pneumonia: 9 people, 9.18%
  6. Bone Marrow Conditioning Regimen: 8 people, 8.16%
  7. High Blood Pressure: 7 people, 7.14%
  8. Infection: 6 people, 6.12%
  9. Constipation: 6 people, 6.12%
  10. Thrombocytopenia (decrease of platelets in blood): 5 people, 5.10%

* Approximation only. Some reports may have incomplete information.

Do you take Multivitamin and Meropenem?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Multivitamin and Meropenem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Multivitamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Meropenem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Multivitamin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Meropenem and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e and meropenem (the active ingredients of Multivitamin and Meropenem, respectively), and Multivitamin and Meropenem (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: